Skip to main content

Find Clinical Trials

Home
Conditions
Advanced Solid Tumor

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

524 public trials 244 recruiting studies

Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Completed

Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors

NCT01392976

Conditions: Advanced Solid Tumor, Neoplasms
Locations: The Netherlands Cancer Institute Amsterdam, Netherlands

Maastricht University Medical Center Maastricht, Netherlands

University Medical Center Utrecht Utrecht, Netherlands

View Trial Details

Completed

Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors

NCT01455571

Conditions: Advanced Solid Tumor
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies

NCT00449280

Conditions: Advanced Solid Tumor, Neoplasm Metastasis, Neoplasms, +3 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

NCT01755390

Conditions: Advanced Solid Tumor
Locations: Sanofi Paris, France

Sanofi Barcelona, Spain

View Trial Details

Completed

QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors

NCT01106248

Conditions: Advanced Solid Tumor, Neoplasms
Locations: Medicale Dunkirk, *CS, France

Service d'Oncologie Dunkirk, *CS, France

View Trial Details

Completed

A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors

NCT00502567

Conditions: Advanced Solid Tumor
Locations: Research Site Ann Arbor, Michigan, United States

Research Site Detroit, Michigan, United States

Research Site Nashville, Tennessee, United States

View Trial Details

Completed

Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases

NCT00501605

Conditions: Advanced Solid Tumor, Liver Metastases
Locations: Research Site Freiburg im Breisgau, Germany

View Trial Details

Completed

Phase 1 Study With Sorafenib and Sirolimus

NCT00509613

Conditions: Advanced Solid Tumor, Refractory to Standard Therapies
Locations: UMC St Radboud Nijmegen, Netherlands

View Trial Details

Completed

A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan

NCT00503477

Conditions: Advanced Solid Tumor
Locations: Research Site Shizuoka, Japan

Research Site Tokyo, Japan

View Trial Details

Terminated

RVU120 (SEL120) in Patients With Relapse/Refractory Metastatic or Advanced Solid Tumors

NCT05052255

Conditions: Advanced Solid Tumor, Disease Attributes, Neoplasm Metastasis, +5 more
Locations: Beskidzkie Centrum Onkologii, Szpital Miejski im. Bielsko-Biala, Poland

Medical University Early Phase 1 Research Center / Uniwersyteckie Centrum Kliniczne Ośrodek Badań Klinicznych Wczesnych Faz Gdansk, Poland

UCK im. prof. K. Gibińskiego Katowice, Poland

Maria Sklodowska-Curie National Research Institute of Oncology / Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Warsaw, Poland

View Trial Details